Exchange: NASDAQ·Updated 07:53 PM EST
ATHE logo

ATHE Alterity Therapeutics Ltd - ADR

$2.44
$0.03
(1.22%)
Today
Closed $2.44
$0.0217
(0.89%)
After Hours
Mkt Cap$46.59M
Vol131,498.00

About ATHE

Alterity Therapeutics Ltd. engages in the business of research and development of therapeutic drugs designed to treat neurodegenerative diseases, focusing on Parkinsonian and other movement disorders. Its lead candidate, ATH434, is an oral small molecule drug designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
60

Bullish Sentiment

How do you feel about ATHE?

Bob_Coyle
$ATHE so we finished at 183X normal volume. The bulk of the buys underwater. Who was desperate to build a 3m+ share position in one day... ASX rules require filing within 2 days for positions over 5%. Tick tok
6
Botmax
$ATHE The company just changed the terms of the CEOs employment and separation payment regarding M&A.
1
3
GA09
$ATHE On the positive side, CEO stated they continue to have "ongoing discussions" & "new prospective partners" are also speaking to ATHE & CEO and the Management Team is aware of the dilution risk to existing shareholders if they go the capital raise route. He said they are looking at multiple approaches and they will only agree on a partnership if that partner is willing to develop 434 along with them and support them (fully) through out the process and not simply finance the trial only to drop off later and for ATHE to do a capital raise (in between the trial) and dilute the existing shareholders. He also said they have sufficient capital for the "initial phase of the trial" which means they know that the trial will be costly and they will (eventually) need funding for the full trial which is why they are looking at a potential partnership structure. Wall Street is not confident they find a partner given the sell off in the stock price. CEO has to prove them wrong soon!!!!
5
ButcherBillCutting
$ATHE I too never thought below $3.0 would Show up again. 3.30 at worst, but we are never in control. I started averaging up more too early😂 I was adding $4.50 all the way to 2.86 Starting at 3.30 woulda been cool. Gotta be patient thru the boredom Nothing I can do about that now Either way, happy to have more size. GL timing the bottom tick in this low liq ADR, that’s why I spread it out. Bottom soon, if not already. If you need to “sell for a loss,” by all means. I enjoy adding more at a heavy Absurd discount. Better than 4.50 😂
5
BrokersNY
$ATHE will add around 10k more shares if drops below 2.80. These valuations are joke atm
5
GA09
$ATHE I listened to the Fireside Chat (this morning) & CEO was asked about plans for financing the Phase 3 trial. He did say they are getting new prospective partners and continuing to have discussions BUT they are also looking at a capital raise (which he admitted was a concern to existing shareholders due to dilution) only if the partner does not provide the value they are looking for in advancing 434 to ultimately being approved by the FDA. He said they are not simply looking for a partner to finance the Phase 3 trial but a strategic partner that is going to bring value to 434. It appears (so far) the partners are not offering the strategic value ATHE is looking for in a partner. Honestly, CEO did not seem optimistic on securing a partner (given his tone) BUT he is also not in support for a capital raise causing dilution. He did say they are still having "ongoing discussions" with potential partners. The partner should be "thoughtful development partner" & not simply a finance.
4
MRenton
$ATHE lack of news on its phase 3 strategy is putting heavy pressure on the price. A pity to have “diminished “ the amazing momentum it had
4
GA09
$ATHE CEO doing another presentation on October 12th in Australia where investors will be present and he will be meeting with them. A lot of discussions taking place with pharma and investors. Will be interesting to see if they can clinch a partnership.
4
AshleySchaeffer_BMW
$ATHE odd activity today, yanked it above 3 then back down, thesis remains, moon soon here...
2
BottomSetups
Next Big CHINA ticker breaking out over at ATPC.🚨 ATPC just 1M float can go like OMH. If you missed OMH, make sure not to miss out on ATPC!!🚨 ATPC shorts are going to get squeezed today! $ATHE $SAIQ ./.1
1
motherlandreturns
$ATHE woah what’s going on I hope a partnership is coming down the pipeline we have been waiting the whole year
1
MRenton
$ATHE The bullish interpretation is that protecting unvested compensation can reduce a CEO’s personal resistance to selling the company
2
SaylorsPonz
$ATHE good thing $PARA.X is not listed here , else some or those 68 million bags might be you !!! $MERC $GRAB the popcorn
1
tommy_john
$ATHE closed a major gap today. But the downtrend has been long. Would have to see non gap reversals 3-5% moves
tommy_john
$ATHE its a shame that FDA takes so long for these things. Especially when results are so good. Many are suffering.

Advertisement|Remove ads.